Blue water biotech reports first quarter 2023 financial results and recent business highlights

Cincinnati, may 12, 2023 (globe newswire) -- blue water biotech, inc. (“blue water” or the “company”), a biotechnology company spanning multiple sectors, today announced its financial results for the quarter ended march 31, 2023 and provided an update on recent business developments and company progress. blue water biotech is a biological and pharmaceutical technology company developing multiple preclinical vaccine candidates across various infectious diseases and owns the fda-approved benign hyperplasia (“bph”) asset, entadfi®.
BWV Ratings Summary
BWV Quant Ranking